Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1867

1.

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, Kiyota N, Homma A, Holeckova P, Del Campo JM, Asarawala N, Nicolau UR, Rauch D, Even C, Wang B, Gibson N, Ehrnrooth E, Harrington K, Cohen EEW; LUX-Head & Neck 2 investigators.

JAMA Oncol. 2019 Jun 13. doi: 10.1001/jamaoncol.2019.1146. [Epub ahead of print]

PMID:
31194247
2.

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition).

Head and Neck Cancer Study Group (HNCSG), Monden N, Asakage T, Kiyota N, Homma A, Matsuura K, Hanai N, Kodaira T, Zenda S, Fujii H, Tahara M, Yokota T, Akimoto T, Iwae S, Onitsuka T, Ogawa T, Okano S, Takahashi S, Shimizu Y, Yonezawa K, Hayashi R.

Jpn J Clin Oncol. 2019 Jun 13. pii: hyz052. doi: 10.1093/jjco/hyz052. [Epub ahead of print]

PMID:
31194232
3.

Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.

Ono D, Shishido-Hara Y, Mizutani S, Mori Y, Ichinose K, Watanabe M, Tanizawa T, Yokota T, Uchihara T, Fujigasaki H.

Neuropathology. 2019 Jun 2. doi: 10.1111/neup.12562. [Epub ahead of print]

PMID:
31155757
4.

Prognostic impact of body mass index and culprit lesion calcification in patients with acute myocardial infarction.

Yokoyama H, Higuma T, Endo T, Nishizaki F, Hanada K, Yokota T, Yamada M, Okumura K, Tomita H.

Heart Vessels. 2019 May 29. doi: 10.1007/s00380-019-01439-5. [Epub ahead of print]

PMID:
31144097
5.

Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease.

Uehara T, Choong CJ, Nakamori M, Hayakawa H, Nishiyama K, Kasahara Y, Baba K, Nagata T, Yokota T, Tsuda H, Obika S, Mochizuki H.

Sci Rep. 2019 May 21;9(1):7567. doi: 10.1038/s41598-019-43772-9.

6.

Prevalence and clinicoradiological features of spinocerebellar ataxia type 34 in a Japanese ataxia cohort.

Ozaki K, Ansai A, Nobuhara K, Araki T, Kubodera T, Ishii T, Higashi M, Sato N, Soga K, Mizusawa H, Ishikawa K, Yokota T.

Parkinsonism Relat Disord. 2019 May 13. pii: S1353-8020(19)30241-X. doi: 10.1016/j.parkreldis.2019.05.019. [Epub ahead of print]

PMID:
31105016
7.

Selective Correction of Genotype Yield by Probucol in HDL-Deficient Mice Propagation.

Tsujita M, Akita N, Yokota T, Kobayashi F, Yokoyama S.

J Atheroscler Thromb. 2019 May 14. doi: 10.5551/jat.48967. [Epub ahead of print]

8.

Cutaneous diffuse large B-cell lymphoma mimicking rheumatoid vasculitis.

Waki D, Nishimura K, Kadoba K, Yokota T.

Rheumatology (Oxford). 2019 May 12. pii: kez193. doi: 10.1093/rheumatology/kez193. [Epub ahead of print] No abstract available.

PMID:
31081032
9.

Anti-proliferative Activities towards Human Brain Glioma U251 Cells and Human Carcinoma Cells (KB3-1) of Some Twin-Drug Type Bivalent C2-Symmetrical Phenylboronic Acid Derivatives.

Furutachi M, Gondo T, Ikeda R, Yoshikawa N, Yokota T, Takeda Y, Yokomizo K, Zhou JR, Kashige N, Miake F, Sumoto K.

Biol Pharm Bull. 2019;42(5):833-836. doi: 10.1248/bpb.b18-00859.

10.

Elevated lipid peaks during the recovery phase of Baló's concentric sclerosis: A case report.

Otsu S, Ishibashi S, Ozaki K, Yokota T.

eNeurologicalSci. 2019 Apr 9;15:100191. doi: 10.1016/j.ensci.2019.100191. eCollection 2019 Jun. No abstract available.

11.

Efficacy of Plasma Exchange in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.

Nishimura K, Waki D, Kadoba K, Mukoyama H, Yokota T, Murabe H.

Ther Apher Dial. 2019 Apr 29. doi: 10.1111/1744-9987.12828. [Epub ahead of print]

PMID:
31033197
12.

Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report.

Sakai T, Yahagi K, Hoshino T, Yokota T, Tanabe K, Mori M, Ikeda S.

Respir Med Case Rep. 2019 Apr 15;27:100839. doi: 10.1016/j.rmcr.2019.100839. eCollection 2019.

13.

Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.

Furukawa F, Ishikawa K, Yokota T, Sanjo N.

Eur Neurol. 2019;81(1-2):13-18. doi: 10.1159/000499909. Epub 2019 Apr 23.

PMID:
31013498
14.

Detection of AD-specific four repeat tau with deamidated asparagine residue 279-specific fraction purified from 4R tau polyclonal antibody.

Ebashi M, Toru S, Nakamura A, Kamei S, Yokota T, Hirokawa K, Uchihara T.

Acta Neuropathol. 2019 Jul;138(1):163-166. doi: 10.1007/s00401-019-02012-0. Epub 2019 Apr 20. No abstract available.

PMID:
31006065
15.

Usefulness of [11C] Methionine PET in the Differentiation of Tumefactive Multiple Sclerosis from High Grade Astrocytoma.

Hashimoto S, Inaji M, Nariai T, Kobayashi D, Sanjo N, Yokota T, Ishii K, Taketoshi M.

Neurol Med Chir (Tokyo). 2019 May 15;59(5):176-183. doi: 10.2176/nmc.oa.2018-0287. Epub 2019 Apr 17.

16.

Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation.

Guo L, Bertola DR, Takanohashi A, Saito A, Segawa Y, Yokota T, Ishibashi S, Nishida Y, Yamamoto GL, Franco JFDS, Honjo RS, Kim CA, Musso CM, Timmons M, Pizzino A, Taft RJ, Lajoie B, Knight MA, Fischbeck KH, Singleton AB, Ferreira CR, Wang Z, Yan L, Garbern JY, Simsek-Kiper PO, Ohashi H, Robey PG, Boyde A, Matsumoto N, Miyake N, Spranger J, Schiffmann R, Vanderver A, Nishimura G, Passos-Bueno MRDS, Simons C, Ishikawa K, Ikegawa S.

Am J Hum Genet. 2019 May 2;104(5):925-935. doi: 10.1016/j.ajhg.2019.03.004. Epub 2019 Apr 11.

PMID:
30982609
17.

The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Naldemedine.

Fukumura K, Yamada T, Yokota T, Kawasaki A.

Clin Pharmacol Drug Dev. 2019 Apr 12. doi: 10.1002/cpdd.690. [Epub ahead of print]

PMID:
30977959
18.

Antisense oligonucleotides for the treatment of cardiomyopathy in Duchenne muscular dystrophy.

Nguyen Q, Yokota T.

Am J Transl Res. 2019 Mar 15;11(3):1202-1218. eCollection 2019. Review.

19.

Association between Daily Life Difficulties and Acceptance of Disability in Cancer Survivors after Total Laryngectomy: a Cross-Sectional Survey.

Teruya N, Sunagawa Y, Toyosato T, Yokota T.

Asia Pac J Oncol Nurs. 2019 Apr-Jun;6(2):170-176. doi: 10.4103/apjon.apjon_50_18.

20.

Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plus nab-paclitaxel chemotherapy: A case report.

Yokota T, Takano S, Yoshitomi H, Kagawa S, Furukawa K, Takayashiki T, Kuboki S, Suzuki D, Sakai N, Nojima H, Mishima T, Nakadai E, Ohtsuka M.

Mol Clin Oncol. 2019 Apr;10(4):419-424. doi: 10.3892/mco.2019.1807. Epub 2019 Feb 4.

21.

ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells.

Takeda Y, Matoba K, Kawanami D, Nagai Y, Akamine T, Ishizawa S, Kanazawa Y, Yokota T, Utsunomiya K.

Int J Mol Sci. 2019 Mar 16;20(6). pii: E1331. doi: 10.3390/ijms20061331.

22.

Optimization of the Photon Path Length Probability Density Function-Simultaneous (PPDF-S) Method and Evaluation of CO₂ Retrieval Performance Under Dense Aerosol Conditions.

Iwasaki C, Imasu R, Bril A, Oshchepkov S, Yoshida Y, Yokota T, Zakharov V, Gribanov K, Rokotyan N.

Sensors (Basel). 2019 Mar 12;19(5). pii: E1262. doi: 10.3390/s19051262.

23.

Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosis.

Nakajima T, Yokota T, Shingu Y, Yamada A, Iba Y, Ujihira K, Wakasa S, Ooka T, Takada S, Shirakawa R, Katayama T, Furihata T, Fukushima A, Matsuoka R, Nishihara H, Dela F, Nakanishi K, Matsui Y, Kinugawa S.

Sci Rep. 2019 Mar 5;9(1):3535. doi: 10.1038/s41598-019-40419-7.

24.

Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient.

Suzuki S, Naito S, Numasawa Y, Asada M, Shoji N, Zeniya M, Takahashi D, Sato H, Iimori S, Nomura N, Sohara E, Okado T, Ishiwata Y, Nagata M, Rai T, Yokota T, Uchida S.

Intern Med. 2019 Jun 15;58(12):1775-1779. doi: 10.2169/internalmedicine.1785-18. Epub 2019 Feb 25.

25.

[The Immune Checkpoints Inhibitors for Head and Neck Cancer].

Yokota T.

Gan To Kagaku Ryoho. 2019 Jan;46(1):21-27. Japanese.

PMID:
30765636
26.

Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle.

Miyatake S, Mizobe Y, Tsoumpra MK, Lim KRQ, Hara Y, Shabanpoor F, Yokota T, Takeda S, Aoki Y.

Mol Ther Nucleic Acids. 2019 Mar 1;14:520-535. doi: 10.1016/j.omtn.2019.01.008. Epub 2019 Jan 25.

27.

Diastolic Intra-Left Ventricular Pressure Difference During Exercise: Strong Determinant and Predictor of Exercise Capacity in Patients With Heart Failure.

Tsujinaga S, Iwano H, Sarashina M, Hayashi T, Murayama M, Ichikawa A, Nakabachi M, Nishino H, Yokoyama S, Fukushima A, Yokota T, Okada K, Kaga S, Vlachos PP, Anzai T.

J Card Fail. 2019 Apr;25(4):268-277. doi: 10.1016/j.cardfail.2019.02.005. Epub 2019 Feb 10.

PMID:
30753935
28.

[Severe interstitial lung disease after one cycle of nivolumab treatment in a patient with advanced gastric cancer].

Shimada S, Ando T, Yokota T, Sakumura M, Yoshita H, Nanjo S, Mihara H, Kajiura S, Fujinami H, Yasuda I.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(2):153-160. doi: 10.11405/nisshoshi.116.153. Japanese.

PMID:
30745553
29.

Outcomes After Aortic Valve Replacement for Asymptomatic Severe Aortic Regurgitation and Normal Ejection Fraction.

Maeda S, Taniguchi K, Toda K, Funatsu T, Kondoh H, Yokota T, Kainuma S, Daimon T, Yoshikawa Y, Sawa Y; Osaka Cardiovascular Surgery Research (OSCAR) Group.

Semin Thorac Cardiovasc Surg. 2019 Feb 5. pii: S1043-0679(19)30024-3. doi: 10.1053/j.semtcvs.2019.02.005. [Epub ahead of print]

PMID:
30731192
30.

The Embryonic Stem Cell-Specific Transcription Factor ZFP57 Promotes Liver Metastasis of Colorectal Cancer.

Shoji Y, Takamura H, Ninomiya I, Fushida S, Tada Y, Yokota T, Ohta T, Koide H.

J Surg Res. 2019 May;237:22-29. doi: 10.1016/j.jss.2018.11.014. Epub 2019 Jan 22.

PMID:
30694787
31.

Facile preparation of optically active jasmonates and their biological activities in rice.

Miyamoto K, Matsumoto T, Yumoto E, Sakazawa T, Yokota T, Yamane H, Uchida K.

Biosci Biotechnol Biochem. 2019 May;83(5):876-881. doi: 10.1080/09168451.2019.1569500. Epub 2019 Jan 24.

PMID:
30676297
32.

Artificial cationic peptides that increase nuclease resistance of siRNA without disturbing RNAi activity.

Maeda Y, Iwata Hara R, Nishina K, Yoshida-Tanaka K, Sakamoto T, Yokota T, Wada T.

Nucleosides Nucleotides Nucleic Acids. 2019;38(5):338-348. doi: 10.1080/15257770.2018.1543890. Epub 2019 Jan 19.

PMID:
30663497
33.

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Hamauchi S, Yokota T, Mizumachi T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H, Homma A.

Int J Clin Oncol. 2019 May;24(5):468-475. doi: 10.1007/s10147-018-01392-9. Epub 2019 Jan 17.

PMID:
30656463
34.

Ultrasound-guided placement of a midline catheter in a patient with extensive postburn contractures: A Case report.

Yokota T, Tokumine J, Lefor AK, Hasegawa A, Yorozu T, Asao T.

Medicine (Baltimore). 2019 Jan;98(3):e14208. doi: 10.1097/MD.0000000000014208.

35.

Thrombotic microangiopathy during the fetal period.

Ishimori S, Ohyama S, Yokota T, Morisawa T, Yonetani M.

Pediatr Int. 2018 Jul;60(7):675-676. doi: 10.1111/ped.13596. No abstract available.

PMID:
30648352
36.

Vitamin C and vitamin E double-deficiency increased neuroinflammation and impaired conditioned fear memory.

Takahashi K, Yanai S, Takisawa S, Kono N, Arai H, Nishida Y, Yokota T, Endo S, Ishigami A.

Arch Biochem Biophys. 2019 Mar 15;663:120-128. doi: 10.1016/j.abb.2019.01.003. Epub 2019 Jan 8.

PMID:
30629958
37.

Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches.

Shimizu-Motohashi Y, Komaki H, Motohashi N, Takeda S, Yokota T, Aoki Y.

J Pers Med. 2019 Jan 7;9(1). pii: E1. doi: 10.3390/jpm9010001. Review.

38.

Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies.

Saito Y, Yokota T, Arai M, Tada Y, Sumitani M.

J Pain Res. 2018 Dec 24;12:127-138. doi: 10.2147/JPR.S175900. eCollection 2019.

39.

Remarkable improvement in progressive multifocal leukoencephalopathy following acute pyelonephritis with bacteremia.

Amano E, Ozaki K, Ishibashi S, Sanjo N, Yokota T.

J Clin Neurosci. 2019 Apr;62:226-228. doi: 10.1016/j.jocn.2018.12.034. Epub 2019 Jan 3.

PMID:
30612916
40.

Ultrasoft electronics to monitor dynamically pulsing cardiomyocytes.

Lee S, Sasaki D, Kim D, Mori M, Yokota T, Lee H, Park S, Fukuda K, Sekino M, Matsuura K, Shimizu T, Someya T.

Nat Nanotechnol. 2019 Feb;14(2):156-160. doi: 10.1038/s41565-018-0331-8. Epub 2018 Dec 31.

PMID:
30598525
41.

Resistance training with interval blood flow restriction effectively enhances intramuscular metabolic stress with less ischemic duration and discomfort.

Okita K, Takada S, Morita N, Takahashi M, Hirabayashi K, Yokota T, Kinugawa S.

Appl Physiol Nutr Metab. 2018 Dec 19:1-6. doi: 10.1139/apnm-2018-0321. [Epub ahead of print]

PMID:
30566362
42.

Clinical characteristics and short-term outcomes in patients with acute cholecystitis over aged >80 years.

Akasu T, Kinoshita A, Imai N, Hirose Y, Yamaguchi R, Yokota T, Iwaku A, Koike K, Saruta M.

Geriatr Gerontol Int. 2019 Mar;19(3):208-212. doi: 10.1111/ggi.13588. Epub 2018 Dec 14.

PMID:
30549172
43.

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges.

Echigoya Y, Lim KRQ, Nakamura A, Yokota T.

J Pers Med. 2018 Dec 7;8(4). pii: E41. doi: 10.3390/jpm8040041. Review.

44.

Impact of admission liver stiffness on long-term clinical outcomes in patients with acute decompensated heart failure.

Omote K, Nagai T, Asakawa N, Kamiya K, Tokuda Y, Aikawa T, Fukushima A, Noguchi K, Kato Y, Komoriyama H, Nishida M, Kudo Y, Iwano H, Yokota T, Anzai T.

Heart Vessels. 2019 Jun;34(6):984-991. doi: 10.1007/s00380-018-1318-y. Epub 2018 Dec 6.

PMID:
30523443
45.

Intermediate-term outcomes of our original multiple-knot technique using ePTFE sutures for anterior mitral leaflet prolapse.

Maeda S, Funatsu T, Kondoh H, Shibukawa T, Yokota T, Kainuma S, Toda K, Sawa Y, Taniguchi K.

Surg Today. 2019 Apr;49(4):350-356. doi: 10.1007/s00595-018-1745-5. Epub 2018 Dec 6.

PMID:
30523410
46.

Two cases of late-onset neuromyelitis optica spectrum disorder initially presenting with isolated cerebral white matter lesions.

Otani T, Irioka T, Takahashi YK, Soga K, Igarashi S, Kaneko K, Takahashi T, Yokota T.

eNeurologicalSci. 2018 Nov 19;13:35-37. doi: 10.1016/j.ensci.2018.11.008. eCollection 2018 Dec. No abstract available.

47.

A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.

Sanjo N, Nose Y, Shishido-Hara Y, Mizutani S, Sekijima Y, Aizawa H, Tanizawa T, Yokota T.

J Neurol. 2019 Feb;266(2):369-377. doi: 10.1007/s00415-018-9140-0. Epub 2018 Dec 3.

PMID:
30511098
48.

Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy.

Lim KRQ, Yoon C, Yokota T.

J Pers Med. 2018 Nov 24;8(4). pii: E38. doi: 10.3390/jpm8040038. Review.

49.

Addition of melphalan to fludarabine/busulfan (FLU/BU4/MEL) provides survival benefit for patients with myeloid malignancy following allogeneic bone-marrow transplantation/peripheral blood stem-cell transplantation.

Ueda T, Maeda T, Kusakabe S, Fujita J, Fukushima K, Yokota T, Shibayama H, Tomiyama Y, Kanakura Y.

Int J Hematol. 2019 Feb;109(2):197-205. doi: 10.1007/s12185-018-2562-8. Epub 2018 Nov 17.

PMID:
30448938
50.

Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates.

Lim KRQ, Echigoya Y, Nagata T, Kuraoka M, Kobayashi M, Aoki Y, Partridge T, Maruyama R, Takeda S, Yokota T.

Mol Ther. 2019 Jan 2;27(1):76-86. doi: 10.1016/j.ymthe.2018.10.011. Epub 2018 Oct 19.

PMID:
30448197

Supplemental Content

Loading ...
Support Center